Kevin Brennan

Kevin Brennan is recorded as CFO and Chief Accounting Officer at Xilio Therapeutics, Inc. (XLO) since March 30, 2023. Xilio Therapeutics, Inc. reported in an 8-K filed April 3, 2023 that Kevin Brennan was appointed principal accounting officer, effective March 30, 2023. Xilio Therapeutics, Inc. reported in an 8-K filed April 3, 2023 that Kevin Brennan was appointed Senior Vice President, Finance and Accounting, and principal financial officer and principal accounting officer, effective March 30, 2023. Xilio Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Xilio Therapeutics, Inc. includes René Russo (CEO and Board Member), Sara M. Bonstein (Chairman and Board Member), Christopher Frankenfield (COO) and 7 others.